Kamil Ali-jackson - Net Worth and Insider Trading
Kamil Ali-jackson Net Worth
The estimated net worth of Kamil Ali-jackson is at least $401,047 dollars as of 2024-11-13. Kamil Ali-jackson is the Chief Legal Officer of Aclaris Therapeutics Inc and owns about 143,618 shares of Aclaris Therapeutics Inc (ACRS) stock worth over $366,226. Kamil Ali-jackson is also the Director of PDS Biotechnology Corp and owns about 11,764 shares of PDS Biotechnology Corp (PDSB) stock worth over $34,821. Details can be seen in Kamil Ali-jackson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kamil Ali-jackson has not made any transactions after 2021-06-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kamil Ali-jackson
Kamil Ali-jackson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kamil Ali-jackson owns 3 companies in total, including PDS Biotechnology Corp (PDSB) , Aclaris Therapeutics Inc (ACRS) , and Rigel Pharmaceuticals Inc (RIGL) .
Click here to see the complete history of Kamil Ali-jackson’s form 4 insider trades.
Insider Ownership Summary of Kamil Ali-jackson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PDSB | PDS Biotechnology Corp | 2021-06-15 | director |
| ACRS | Aclaris Therapeutics Inc | 2021-05-07 | Chief Legal Officer |
| RIGL | Rigel Pharmaceuticals Inc | 2022-05-20 | director |
Kamil Ali-jackson Latest Holdings Summary
Kamil Ali-jackson currently owns a total of 2 stocks. Among these stocks, Kamil Ali-jackson owns 143,618 shares of Aclaris Therapeutics Inc (ACRS) as of May 7, 2021, with a value of $366,226 and a weighting of 91.32%. Kamil Ali-jackson also owns 11,764 shares of PDS Biotechnology Corp (PDSB) as of June 15, 2021, with a value of $34,821 and a weighting of 8.68%.
Latest Holdings of Kamil Ali-jackson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics Inc | 2021-05-07 | 143,618 | 2.55 | 366,226 |
| PDSB | PDS Biotechnology Corp | 2021-06-15 | 11,764 | 2.96 | 34,821 |
Holding Weightings of Kamil Ali-jackson
Kamil Ali-jackson Form 4 Trading Tracker
According to the SEC Form 4 filings, Kamil Ali-jackson has made a total of 2 transactions in Aclaris Therapeutics Inc (ACRS) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Aclaris Therapeutics Inc is the sale of 20,416 shares on May 7, 2021, which brought Kamil Ali-jackson around $478,755.
According to the SEC Form 4 filings, Kamil Ali-jackson has made a total of 1 transactions in PDS Biotechnology Corp (PDSB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in PDS Biotechnology Corp is the acquisition of 11,764 shares on June 15, 2021, which cost Kamil Ali-jackson around $99,994.
Insider Trading History of Kamil Ali-jackson
- 1
Kamil Ali-jackson Trading Performance
GuruFocus tracks the stock performance after each of Kamil Ali-jackson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kamil Ali-jackson is 66.3%. GuruFocus also compares Kamil Ali-jackson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kamil Ali-jackson within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kamil Ali-jackson's insider trading performs compared to the benchmark.
Performance of Kamil Ali-jackson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.2 | | | | | |
| Relative Return to S&P 500(%) | 3.53 | | | | | |
Kamil Ali-jackson Ownership Network
Ownership Network List of Kamil Ali-jackson
Ownership Network Relation of Kamil Ali-jackson
Kamil Ali-jackson Owned Company Details
What does PDS Biotechnology Corp do?
Who are the key executives at PDS Biotechnology Corp?
Kamil Ali-jackson is the director of PDS Biotechnology Corp. Other key executives at PDS Biotechnology Corp include Senior VP & General Counsel Spencer D. Brown , Chief Financial Officer Matthew C Hill , and director & 10 percent owner Delyle W Bloomquist .
PDS Biotechnology Corp (PDSB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of PDS Biotechnology Corp (PDSB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PDS Biotechnology Corp (PDSB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
PDS Biotechnology Corp (PDSB)'s detailed insider trading history can be found in Insider Trading Tracker table.
PDS Biotechnology Corp Insider Transactions
Kamil Ali-jackson Mailing Address
Above is the net worth, insider trading, and ownership report for Kamil Ali-jackson. You might contact Kamil Ali-jackson via mailing address: C/o Aclaris Therapeutics, Inc., 101 Lindenwood Drive, Suite 400, Malvern Pa 19355.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
